Methodology
How we evaluate providers
Our goal is to be the single most trustworthy reference for choosing a GLP-1 provider in the US. Here is exactly how the comparison gets built, verified, and kept fresh.
Who we include
To appear on the list, a provider must:
- Be actively prescribing in at least three US states.
- Publish pricing — or make it obtainable through a free intake.
- Have no active FDA warning letter.
- Provide medical oversight (not be a marketplace or referral-only site).
We explicitly exclude research-chemical sellers, "peptide" sites that don't require a prescription, and anyone selling injectables without a licensed prescriber in the loop.
What we record for each provider
Every entry captures the same ~22 fields, grouped into five buckets:
- Identity — name, website, year founded, HQ state.
- Medication & sourcing — which medications are offered, branded vs compounded, and (for compounded) the partner pharmacy and 503A/503B status.
- Access & process — states served, consult type, time to first dose, insurance, lab requirements, eligibility.
- Cost — intake fee, monthly price at the lowest dose, monthly price at maintenance dose, shipping, pause/cancel terms, refund policy.
- Clinical oversight — prescriber type, follow-up cadence, side-effect protocol, maintenance & discontinuation guidance.
How we verify
For each provider, an editor:
- Reads the provider's pricing page, terms of service, FAQ, and clinical model.
- Completes a free intake where one is offered, to see real pricing and process.
- Cross-checks against the FDA warning-letter database, state pharmacy boards, BBB, and Trustpilot.
- Stamps the entry with a last verified date and the verifier's initials.
Every row on the comparison shows that date. If we know an entry needs re-verification (for example, a pricing page just changed), it's flagged in the table.
How often we update
- Pricing and states served: monthly full re-verification.
- Medication offerings and clinical model: quarterly.
- Major FDA or market events (e.g. a compounding rule change, a new drug approval): updated within 72 hours and flagged at the top of the page.
We also run lightweight automated checks against each provider's pricing page so we see changes between manual reviews. Automated checks never publish edits — they only queue a row for an editor to re-verify.
How we handle affiliate relationships
We may link to providers through affiliate links so the site can sustain its independent reporting. When we do:
- Every affiliate link is clearly marked.
- Ranking, sort order, and inclusion are never affected by whether we earn a commission.
- We do not accept pay-to-be-listed or paid placement.
Each provider page shows whether we currently have an affiliate relationship with that specific provider.
Reporting corrections
If something on this site is wrong, please tell us. Email editors@thepeptidegps.com with the provider name and the specific field that needs updating. We aim to investigate within five business days.